Reduced mortality in dermatitis herpetiformis: A population-based study of 476 patients

British Journal of Dermatology

Volumn 167, Issue 6, 2012, Pages 1331-1337

  Hervonen, K ^a,b   Alakoski, A ^a   Salmi, T T ^a,b   Helakorpi, S ^c   Kautiainen, H ^d   Kaukinen, K ^a,b   Pukkala, E ^a,e   Collin, P ^a,b   Reunala, T ^a,b  

^a TAMPERE UNIVERSITY HOSPITAL   (Finland)

^b TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^c NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^d Unit of Primary Health Care   (Finland)

^e FINNISH CANCER REGISTRY   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CAUSE OF DEATH; CEREBROVASCULAR DISEASE; CHILD; CONTROLLED STUDY; DERMATITIS HERPETIFORMIS; FEMALE; FOLLOW UP; HUMAN; HYPERCHOLESTEROLEMIA; INTESTINE VILLUS ATROPHY; MAJOR CLINICAL STUDY; MALE; MORTALITY; POPULATION BASED CASE CONTROL STUDY; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CAUSE OF DEATH; CELIAC DISEASE; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; DERMATITIS HERPETIFORMIS; DIET, GLUTEN-FREE; FEMALE; FINLAND; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; QUESTIONNAIRES; YOUNG ADULT;

EID: 84870228087     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2012.11105.x     Document Type: Article

References (42)

1. Kárpáti S,. Dermatitis herpetiformis. Clin Dermatol 2012; 30: 56-9.
2. Gawkrodger DJ, Blackwell JN, Gilmour HM, et al. Dermatitis herpetiformis: diagnosis, diet and demography. Gut 1984; 25: 151-7.
3. Savilahti E, Reunala T, Mäki M,. Increase of lymphocytes bearing the gamma/delta T cell receptor in the jejunum of patients with dermatitis herpetiformis. Gut 1992; 33: 206-11.
4. Fry L, Seah PP, Riches DJ, Hoffbrand AV,. Clearance of skin lesions in dermatitis herpetiformis after gluten withdrawal. Lancet 1973; 1: 288-91.
5. Reunala T, Blomqvist K, Tarpila S, et al. Gluten-free diet in dermatitis herpetiformis. I. Clinical response of skin lesions in 81 patients. Br J Dermatol 1977; 97: 473-80.
6. Leonard JN, Fry L,. Treatment and management of dermatitis herpetiformis. Clin Dermatol 1991; 9: 403-8.
7. Salmi TT, Hervonen K, Kautiainen H, et al. Prevalence and incidence of dermatitis herpetiformis: a 40-year prospective study from Finland. Br J Dermatol 2011; 165: 354-9.
8. Logan RF, Rifkind EA, Turner ID, Ferguson A,. Mortality in celiac disease. Gastroenterology 1989; 97: 265-71.
9. Cottone M, Termini A, Oliva L, et al. Mortality and causes of death in celiac disease in a Mediterranean area. Dig Dis Sci 1999; 44: 2538-41.
10. Corrao G, Corazza G, Bagnardi V, et al. Mortality in patients with celiac disease and their relatives: a cohort study. Lancet 2001; 358: 356-61.
11. Peters U, Askling J, Gridley G, et al. Causes of death in patients with celiac disease in a population-based Swedish cohort. Arch Intern Med 2003; 163: 1566-72.
12. West J, Logan RF, Smith CJ, et al. Malignancy and mortality in people with celiac disease: population based cohort study. BMJ 2004; 329: 716-19.
13. Biagi F, Corazza GR,. Mortality in celiac disease. Nat Rev Gastroenterol Hepatol 2010; 7: 158-62.
14. Leonard JN, Tucker WFG, Fry JS, et al. Increased risk of malignancy in dermatitis herpetiformis. BMJ 1983; 286: 16-18.
15. Sigurgeirsson B, Agnarsson BA, Lindelöf B,. Risk of lymphoma in patients with dermatitis herpetiformis. BMJ 1994; 308: 13-15.
16. Collin P, Pukkala E, Reunala T,. Malignancy and survival in dermatitis herpetiformis: a comparison with coeliac disease. Gut 1996; 38: 528-30.
17. Askling J, Linet M, Gridley G, et al. Cancer incidence in a population-based cohort of individuals hospitalized with celiac disease or dermatitis herpetiformis. Gastroenterology 2002; 123: 1428-35.
18. Hervonen K, Vornanen M, Kautiainen H, et al. Lymphoma in patients with dermatitis herpetiformis and their first-degree relatives. Br J Dermatol 2005; 152: 82-6.
19. Grainge MJ, West J, Solaymani-Dodaran M, et al. The long-term risk of malignancy following a diagnosis of coeliac disease or dermatitis herpetiformis: a cohort study. Aliment Pharmacol Ther 2012; 35: 730-9.
20. Swerdlow AJ, Whittaker S, Carpenter LM, et al. Mortality and cancer incidence in patients with dermatitis herpetiformis: a cohort study. Br J Dermatol 1993; 129: 140-4.
21. Viljamaa M, Kaukinen K, Pukkala E, et al. Malignancies and mortality in patients with coeliac disease and dermatitis herpetiformis: 30-year population-based study. Dig Liver Dis 2006; 38: 374-80.
22. Lewis NR, Logan RF, Hubbard RB, et al. No increase in risk of fracture, malignancy or mortality in dermatitis herpetiformis: a cohort study. Aliment Pharmacol Ther 2008; 27: 1140-7.
23. Alakoski A, Salmi TT, Hervonen K, et al,. Chronic gastritis in dermatitis herpetiformis: a controlled study. Clin Dev Immunol 2012 [Epub ahead of print. doi: 10.1155/2012/640630].
24. Reunala T, Collin P, Holm K, et al. Tolerance to oats in dermatitis herpetiformis. Gut 1998; 43: 490-3.
25. Tolonen H, Helakorpi S, Talala K, et al. 25-year trends and socio-demographic differences in response rates: Finnish adult health behavior survey. Eur J Epidemiol 2006; 21: 409-15.
26. Helakorpi S, Laitalainen E, Uutela A,. Health Behavior and Health among the Finnish Adult Population, Spring 2009, Report 7/2010. Helsinki: National Institute for Health and Welfare, 2010.
27. Sapone A, Bai JC, Ciacci C, et al. Spectrum of gluten-related disorders: consensus on new nomenclature and classification. BMC Med 2012; 10: 13.
28. Tio M, Cox MR, Eslick GD,. Meta-analysis: coeliac disease and the risk of all-cause mortality, any malignancy and lymphoid malignancy. Aliment Pharmacol Ther 2012; 35: 540-51.
29. Lewis HM, Reunala TL, Garioch JJ, et al. Protective effect of gluten-free diet against development of lymphoma in dermatitis herpetiformis. Br J Dermatol 1996; 135: 363-7.
30. Ludvigsson JF, Montgomery SM, Ekbom A, et al. Small-intestinal histopathology and mortality risk in celiac disease. JAMA 2009; 302: 1171-8.
31. Grainge MJ, West J, Card TR, Holmes GKT,. Causes of death in people with celiac disease spanning the pre- and post-serology era: a population-based cohort study from Derby, UK. Am J Gastroenterol 2011; 106: 933-69.
32. Hall NJ, Rubin G, Charnock A,. Systematic review: adherence to a gluten-free diet in adult patients with coeliac disease. Aliment Pharmacol Ther 2009; 30: 315-30.
33. Leonard J, Haffenden G, Tucker W, et al. Gluten challenge in dermatitis herpetiformis. N Engl J Med 1983; 308: 816-19.
34. Kõsnai I, Kárpati S, Savilahti E, et al. Gluten challenge in children with dermatitis herpetiformis: a clinical, morphological and immunohistological study. Gut 1986; 27: 1464-70.
35. Lähdeaho ML, Mäki M, Laurila K, et al. Small-bowel mucosal changes and antibody responses after low- and moderate-dose gluten challenge in celiac disease. BMC Gastroenterol 2011; 11: 129.
36. Ludvigsson JF, West J, Card T, Appelros P,. Risk of stroke in 28 000 patients with celiac disease: a nationwide cohort study in Sweden. J Stroke Cerebrovasc Dis 2012; 21: 860-7.
37. Ludvigsson JF, James S, Askling J, et al. Nationwide cohort study of risk of ischemic heart disease in patients with celiac disease. Circulation 2011; 123: 483-90.
38. Lear JT, Neary RH, Jones P, et al. Risk factors for ischaemic heart disease in patients with dermatitis herpetiformis. J R Soc Med 1997; 90: 247-9.
39. West J, Logan RF, Hill PG, et al. Seroprevalence, correlates, and characteristics of undetected coeliac disease in England. Gut 2003; 52: 960-5.
40. Brar P, Kwon GY, Holleran S, et al. Change in lipid profile in celiac disease: beneficial effect of gluten-free diet. Am J Med 2006; 119: 786-90.
41. Lewis NR, Sanders DS, Logan RF, et al. Cholesterol profile in people with newly diagnosed coeliac disease: a comparison with the general population and changes following treatment. Br J Nutr 2009; 102: 509-13.
42. Snook JA, Dwyer L, Lee-Elliott C, et al. Adult coeliac disease and cigarette smoking. Gut 1996; 39: 60-2.